Foundayo is the brand name for orforglipron, the first FDA-approved oral GLP-1 for chronic weight management. It is a daily pill made by Eli Lilly with no fasting restrictions.

How much weight can you lose on Foundayo?

Clinical trials show approximately 12-15% body weight loss, slightly less than Zepbound (~20.9%) but comparable to Wegovy (~14.9%).

How much does Foundayo cost?

$149/month via LillyDirect and Amazon Pharmacy, making it the cheapest branded GLP-1.

Is Foundayo the same as Rybelsus?

No. Foundayo is orforglipron (weight loss, no fasting). Rybelsus is oral semaglutide (diabetes, requires fasting).

Does Foundayo require injections?

No. Foundayo is a daily oral tablet — the first GLP-1 pill approved for weight management.

What are the side effects of Foundayo?

Same as other GLP-1s: nausea, diarrhea, constipation, vomiting, fatigue. Typically mild and improve over 4-8 weeks.

Foundayo is the brand name for orforglipron, the first FDA-approved oral GLP-1 medication for chronic weight management. It is a small-molecule GLP-1 receptor agonist made by Eli Lilly, taken as a daily pill without fasting restrictions.

How much weight can you lose on Foundayo?

Late-phase clinical trials showed Foundayo produces approximately 12-15% body weight loss. This is slightly less than injectable tirzepatide (Zepbound, ~20.9%) but comparable to injectable semaglutide (Wegovy, ~14.9%). Individual results vary.

How much does Foundayo cost?

Foundayo costs $149/month via LillyDirect and Amazon Pharmacy, making it the cheapest branded GLP-1 medication. Insurance coverage is expanding but may not yet be available on all plans.

Is Foundayo the same as Rybelsus?

No. Foundayo (orforglipron) is a small-molecule GLP-1 approved for weight management. Rybelsus (oral semaglutide) is a peptide-based GLP-1 approved for type 2 diabetes. Key difference: Foundayo has no fasting requirement, while Rybelsus must be taken on an empty stomach with water and you must wait 30 minutes before eating.

Does Foundayo require injections?

No. Foundayo is a daily oral tablet. This is a major advantage for patients who cannot tolerate or do not want injections. It is the first GLP-1 pill approved specifically for weight management.

What are the side effects of Foundayo?

Foundayo shares the same side effect profile as other GLP-1 medications: nausea, diarrhea, constipation, vomiting, and fatigue. Side effects are typically mild to moderate and improve over 4-8 weeks. Like all GLP-1s, it is contraindicated in people with MTC or MEN2 history.

Foundayo (Orforglipron): The First Oral GLP-1 for Weight Loss

What is Foundayo (orforglipron)?

Foundayo is the brand name for orforglipron, the first FDA-approved oral GLP-1 receptor agonist for chronic weight management. Developed by Eli Lilly, it represents a breakthrough in GLP-1 therapy: a daily pill that does not require injections, does not require fasting, and costs less than every branded injectable GLP-1 on the market.

Unlike Rybelsus (oral semaglutide), which is a peptide-based drug that must be taken on an empty stomach with strict water-only rules, Foundayo is a small-molecule GLP-1 agonist that can be taken with or without food. This makes it dramatically more convenient for daily use.

How Foundayo works

Orforglipron is a non-peptide GLP-1 receptor agonist. It binds to the same GLP-1 receptors in the gut and brain as semaglutide and tirzepatide, producing:

Appetite suppression: Reduced hunger and increased satiety
Slowed gastric emptying: Food stays in the stomach longer, keeping you full
Improved insulin sensitivity: Better blood sugar control
Reduced food cravings: Less desire for high-calorie foods

Because it is a small molecule (not a peptide), orforglipron survives the digestive tract without degradation, which is why it can be taken orally without the strict fasting requirements of Rybelsus.

Expected results

Timepoint	Avg weight loss	What to expect
Month 1	2–4% body weight	Appetite reduction, mild nausea possible
Month 3	5–8% body weight	Noticeable weight loss, side effects improving
Month 6	8–12% body weight	Significant weight loss, stable dose
Month 12	12–15% body weight	Approaching maximum efficacy

Foundayo vs other GLP-1 medications

Feature	Foundayo	Wegovy	Zepbound	Rybelsus
Active ingredient	Orforglipron	Semaglutide	Tirzepatide	Semaglutide (oral)
Form	Daily pill	Weekly injection	Weekly injection	Daily pill
Fasting required?	No	—	—	Yes (30 min before food)
FDA indication	Weight management	Weight management	Weight management + OSA	Type 2 diabetes
Avg weight loss	12–15%	~14.9%	~20.9%	~8–10% (off-label)
Cost/mo	$149	$149–$1,300	$299–$1,050	~$900

Who should consider Foundayo?

Patients who prefer pills over injections — Foundayo eliminates the needle entirely
Budget-conscious patients — at $149/month, it is the cheapest branded GLP-1
Patients who travel frequently — no refrigeration or injection supplies needed
Patients who could not tolerate Rybelsus fasting rules — Foundayo has no food restrictions
Adults with BMI ≥30 (or ≥27 with a weight-related condition)

Who should NOT take Foundayo?

People with personal or family history of medullary thyroid carcinoma (MTC)
People with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Pregnant or breastfeeding women
People with a history of pancreatitis
Patients seeking maximum weight loss (Zepbound may be more effective)

Side effects

Foundayo shares the same side effect profile as other GLP-1 medications. The most common are nausea, diarrhea, constipation, vomiting, and fatigue. These typically peak during the first 4 weeks and improve as your body adjusts. See our complete GLP-1 side effects guide for detailed management strategies.

How to get Foundayo

Foundayo is available through LillyDirect and Amazon Pharmacy at $149/month without insurance. You will need a prescription from a US-licensed provider. Telehealth programs can facilitate the consultation online.

Want to explore your GLP-1 options?

A US-licensed provider can help you decide if Foundayo or another GLP-1 is right for you.

Check my eligibility

Related guides

Medical disclaimer: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any medication.